AU7132596A - Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines - Google Patents

Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines

Info

Publication number
AU7132596A
AU7132596A AU71325/96A AU7132596A AU7132596A AU 7132596 A AU7132596 A AU 7132596A AU 71325/96 A AU71325/96 A AU 71325/96A AU 7132596 A AU7132596 A AU 7132596A AU 7132596 A AU7132596 A AU 7132596A
Authority
AU
Australia
Prior art keywords
vaccines
formulation
recombinant adenoviruses
gastroenteritis virus
express antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71325/96A
Inventor
Luis Enjuanes
Juan Plana Duran
Carlos Miguel Sanchez
Cristian Smerdou
Carles Sune
Juan Maria Torres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Farma SA
Original Assignee
Cyanamid Iberica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyanamid Iberica SA filed Critical Cyanamid Iberica SA
Publication of AU7132596A publication Critical patent/AU7132596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU71325/96A 1995-11-30 1996-10-01 Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines Abandoned AU7132596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES9502370 1995-11-30
ES09502370A ES2105984B1 (en) 1995-11-30 1995-11-30 RECOMBINANT ADENOVIRUSES THAT EXPRESS TRANSMISSIBLE SWINE GASTROENTERITIS VIRUS ANTIGENS (VGPT) AND THEIR USE IN THE FORMATION OF VACCINES.
PCT/ES1996/000185 WO1997020036A1 (en) 1995-11-30 1996-10-01 Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines

Publications (1)

Publication Number Publication Date
AU7132596A true AU7132596A (en) 1997-06-19

Family

ID=8292359

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71325/96A Abandoned AU7132596A (en) 1995-11-30 1996-10-01 Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines

Country Status (3)

Country Link
AU (1) AU7132596A (en)
ES (1) ES2105984B1 (en)
WO (1) WO1997020036A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO856097A0 (en) * 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
FR2789695B1 (en) * 1999-02-11 2003-03-07 Merial Sas VIRAL VACCINES AND VACCINES BASED ON RECOMBINANT AND REPLICATIVE SWINE ADENOVIRUSES
US7569217B2 (en) 2001-09-24 2009-08-04 University Of Saskatchewan Porcine adenovirus E1 and E4 regions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657907B2 (en) * 1990-05-29 1995-03-30 Wyeth Holdings Corporation Mycoplasma hyopneumoniae vaccine

Also Published As

Publication number Publication date
ES2105984B1 (en) 1998-04-16
WO1997020036A1 (en) 1997-06-05
ES2105984A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
AU709406C (en) Combined vaccines comprising hepatitis B surface antigen and other antigens
HUP0004360A3 (en) Papilloma virus capsomere vaccine formulations and methods of use
AU4556597A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
GC0000201A (en) Combined vaccine composition comprising a herpes simplex virus (hsv) antigen and a human papillomavirus (hpv) antigen
AU8762991A (en) Human papilloma viral protein expression for use in vaccine compositions
AU7678196A (en) Methods and compositions for the delivery of monomeric proteins
AU3824595A (en) Recombinant negative strand RNA virus expression systems and vaccines
AU3431297A (en) Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
AU2497292A (en) Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
IL115779A0 (en) Adenoviruses lacking viable contaminating particles preparation and uses thereof
IL96647A0 (en) Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
AU3727695A (en) Compositions and methods for the abrogation of cellular proliferation utilizing the human immunodeficiency virus vpr protein
AU3512797A (en) Porcine reproductive and respiratory syndrome vaccine
AU8113591A (en) Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
HUP0000356A3 (en) Vectors based on recombinant defective viral genomes,and their use in the formulation of vaccines
NZ298224A (en) Recombinant papilloma virus antigens
AU2277497A (en) Porcine reproductive and respiratory syndrome vaccine
AU5297496A (en) Methods of preparation and use of recombinant adenoviral vectors
EP0747482A3 (en) Hepatitis GB virus recombinant proteins and uses thereof
AU7132596A (en) Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines
AU1908395A (en) Antibodies to mammalian natural killer antigens and uses
CA2275259A1 (en) Formulations of recombinant papillomavirus vaccines
AU3755999A (en) Proteins that direct the secretion of virulence proteins and vaccines comprisingthem
AU3670697A (en) Recombinant pox virus for immunization against tumor-associated antigens
AU3232995A (en) Hepatitis a virus deletion mutants and vaccine formulations containing the same